European Society of Cardiology (ESC) Congress 2010

Top Stories From the ESC 2010 Annual Meeting: Slideshow
Research highlights include results from SHIFT, showing that adding ivabradine to heart failure medications cuts mortality and hospitalization; from AVERROES, showing that apixaban yields significant reductions in stroke without an increase in bleeding risk; and new data from PLATO, showing that there is no need for gene testing in patients undergoing percutaneous cardiovascular intervention.

• ESC Athletes ECG Screening
  Heartwire from Medscape, September 13, 2010
• ESC Vulnerable Plaque Distribution
  Heartwire from Medscape, September 9, 2010
• ESC Clopidogrel-PPI and Genetics
  Heartwire from Medscape, September 9, 2010
• ESC NSAIDs and Stroke
  Heartwire from Medscape, September 8, 2010
• ESC ESC Issues New Guidelines on Management of AF
  Heartwire from Medscape, September 7, 2010
• ESC RESPONSE: Nurse Secondary Prevention Programs Feasible for ACS
  Heartwire from Medscape, September 3, 2010
• ESC CARE-HF Long-Term Follow-up Analysis
  Heartwire from Medscape, September 3, 2010
• ESC European Guidelines Recommend CRT for NYHA Class 2 HF
  Heartwire from Medscape, September 1, 2010
• ESC DANPACE
  Heartwire from Medscape, September 1, 2010
• ESC KYOTO and JIKEI HEART at ESC
  Heartwire from Medscape, September 1, 2010
• ESC PACE Update
  Heartwire from Medscape, September 1, 2010
• ESC DES for AMI
  Heartwire from Medscape, September 1, 2010
• ESC AF Treatment Remains Unchanged, New Contemporary Data Show
  Heartwire from Medscape, September 1, 2010
• ESC Angiotensin-Receptor Blocker Doesn't Suppress Paroxysmal AF
  Heartwire from Medscape, August 31, 2010
• ESC New Oral Factor Xa Inhibitor Rivaroxaban in Treatment of DVT
  Heartwire from Medscape, August 31, 2010
• ESC FUTURA/OASIS-8: Heparin & Fondaparinux in PCI
  Heartwire from Medscape, August 31, 2010
• ESC AVERROES Presented at ESC
  Heartwire from Medscape, August 31, 2010
• ESC ART: BIMA vs SIMA in CABG Surgery
  Heartwire from Medscape, August 31, 2010
• ESC ATOLL: Enoxaparin Over UHF in PCI for STEMI
  Heartwire from Medscape, August 30, 2010
• ESC REACH Registry
  Heartwire from Medscape, August 30, 2010
• ESC Statins and Cancer at ESC
  Heartwire from Medscape, August 30, 2010
• ESC First Prospective Study Finds Colchicine Prevents Post-Op Pericarditis
  Heartwire from Medscape, August 30, 2010
• ESC ISAR-REACT 3A: Heparin Dose in PCI
  Heartwire from Medscape, August 30, 2010
• ESC Atopaxar, a PAR-1 Inhibitor, Promising in Phase 2 in ACS and CAD
  Heartwire from Medscape, August 30, 2010
• ESC INNOVATE PCI Presented at ESC
  Heartwire from Medscape, August 30, 2010
• ESC Exercise as Therapy
  Heartwire from Medscape, August 30, 2010
• ESC Everolimus-Eluting Stent Bests Sirolimus
  Heartwire from Medscape, August 30, 2010
• ESC STAR- Heart: Stem-Cell Success
  Heartwire from Medscape, August 29, 2010
• ESC Genetic Substudy Data From PLATO and TRITON-TIMI 38 Published
  Heartwire from Medscape, August 29, 2010
• ESC PEARL-HF: RLY5016 in CHF
  Heartwire from Medscape, August 29, 2010
• ESC RE-LY INR Analysis in Print
  Heartwire from Medscape, August 29, 2010
• ESC New ESC Revascularization Task Force Report
  Heartwire from Medscape, August 29, 2010
• ESC Alpha Omega Trial at ESC
  Heartwire from Medscape, August 29, 2010
• ESC SHIFT Proposes Heart Rate as Treatment Target in Heart Failure
  Heartwire from Medscape, August 29, 2010
• ESC CURE ACTIVE: Clopidogrel Genotype and Event Rates
  Heartwire from Medscape, August 29, 2010
• ESC EPO a No-go in Post-MI Patients
  Heartwire from Medscape, August 29, 2010
• ESC ESC 2010 Congress: What's Going to Be Hot
  Heartwire from Medscape, August 24, 2010